Mark Gudesblatt
- Neurology top 2%
- Botulinum Toxin and Related Neurological Disorders 5
- Neuroinflammation and Neurodegeneration Mechanisms 4
- Peripheral Neuropathies and Disorders 3
- Parkinson's Disease Mechanisms and Treatments 3
-
- Multiple Sclerosis Research Studies 36
- Neurology top 10%
- Botulinum Toxin and Related Neurological Disorders 5
- Neuroinflammation and Neurodegeneration Mechanisms 4
- Peripheral Neuropathies and Disorders 3
- Parkinson's Disease Mechanisms and Treatments 3
- Psychiatry and Mental health top 10%
- Cerebral Palsy and Movement Disorders 3
-
- Polyomavirus and related diseases 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Jeffrey WilkenVijay DhawanDavid EidelbergThomas EckertSteven J. FruchtAndrew FeiginJean‐Paul VonsattelStanley Fahn
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Mark Gudesblatt
55 papers receiving 936 citations
Peers
Comparison fields: 5 of 88
- Neurology 440
- Pathology and Forensic Medicine 459
- Neurology 116
- Psychiatry and Mental health 129
- Cellular and Molecular Neuroscience 145
Countries citing papers authored by Mark Gudesblatt
This map shows the geographic impact of Mark Gudesblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gudesblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gudesblatt more than expected).
Fields of papers citing papers by Mark Gudesblatt
This network shows the impact of papers produced by Mark Gudesblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gudesblatt. The network helps show where Mark Gudesblatt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Gudesblatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 7 | |
| 12 | An Investigation of Headaches in Hypermobile Ehlers- Danlos Syndrome | 2020 | 1 |
| 13 | 2018 | 8 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 15 | |
| 16 | 2017 | 1 | |
| 17 | 2014 | 13 | |
| 18 | 2014 | 1 | |
| 19 | 2013 | 33 | |
| 20 | 2011 | 19 |
About Mark Gudesblatt
Mark Gudesblatt is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology, having authored 61 papers that have together received 959 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (36 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Polyomavirus and related diseases (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Peripheral Neuropathies and Disorders (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Cerebral Palsy and Movement Disorders (3 papers). The work is most often cited by research in Neurology (440 citations), Pathology and Forensic Medicine (459 citations) and Neurology (116 citations). Mark Gudesblatt has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Jeffrey Wilken, Vijay Dhawan, David Eidelberg, Thomas Eckert, Steven J. Frucht, Andrew Feigin, Jean‐Paul Vonsattel, Stanley Fahn, Kathleen L. Poston and Chris C. Tang. Their work appears in journals such as Neurology, The Lancet Neurology and Experimental Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.